The New York Times - Saturday, January 11, 2003
Elizabeth Becker
But he will be met by activists in street protests and officials in conference rooms who will be asking tough questions about American policies on AIDS and farm subsidies.
Specifically, African countries are concerned that the United States blocked a trade deal last month that would have allowed poor countries to import generic versions of patented medicines, and they question why American farmers continue to receive huge subsidies.
African officials quietly say they are insulted that Mr. Zoellick, a junior member of the Bush cabinet, is representing the United States rather than the president, who was scheduled to attend the Africa Trade and Economic Cooperation Forum in Mauritius. President Bush scrapped the trip last month as the administration appeared to step up preparations for a possible war in Iraq.
"We were very sad when we learned that President Bush wouldn't travel to Africa and witness the devastation wrought by AIDS-related illness," said Zackie Achmant, president of the Treatment Action Campaign of South Africa.
At his first stop, in Pretoria, South Africa, Mr. Zoellick will meet with trade ministers of Botswana, Lesotho, Namibia, South Africa and Swaziland in advance of formal talks in February to create a free trade zone in southern Africa with the United States.
Mr. Zoellick said in a statement that a future free trade zone would "give new hope and economic opportunity to the people of southern Africa by increasing trade, creating new jobs, boosting economic growth and development."
Absent from Mr. Zoellick's list of goals for his trip was any mention of the H.I.V.-AIDS pandemic. "Free trade doesn't work for the dead," said Asia Russell, director of international policy of the nonprofit Health Global Access Project. "A modest expansion of trade will be of little comfort to millions of Africans who will die of treatable illnesses."
Ministers at the World Trade Organization failed to resolve the dispute over providing impoverished countries with access to life-saving medicine in talks last month when the United States insisted on limiting access to medicines that treat malaria, tuberculosis and H.I.V./AIDS and a restricted list of other infectious diseases.
At issue is a draft agreement that would allow pharmaceutical companies in developing nations to export generic versions of patented drugs to countries too poor to make the medicine themselves. The corporations holding the patents would not be consulted. The European Union suggested on Thursday that the draft agreement would expand the list of diseases to at least 22 diseases.
030111
NYT030102
Copyright © 2003 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .